-+ 0.00%
-+ 0.00%
-+ 0.00%

U.S. FDA : APPROVES RASONQUE (DARAXONRASIB), FIRST-IN-CLASS RAS INHIBITOR FOR METASTATIC PANCREATIC CANCER

Reuters·08/26/2026 14:38:27

Please log in to view news